Pharmacokinetics of continuous renal replacement therapy.

Suppr

超能文献

作者信息

Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P

机构信息

Department of Intensive Care Medicine, UZ Gasthuisberg, Leuven, Belgium.

出版信息

Intensive Care Med. 1995 Jul;21(7):612-20. doi: 10.1007/BF01700172.

DOI:10.1007/BF01700172

PMID:7593908

Abstract

摘要

相似文献

Pharmacokinetics of continuous renal replacement therapy.

Intensive Care Med. 1995 Jul;21(7):612-20. doi: 10.1007/BF01700172.

Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage.

Kidney Int Suppl. 1999 Nov(72):S24-8.

Drug removal in continuous haemofiltration and haemodialysis.

Br J Hosp Med. 1995;54(10):524-8.

Drug administration in critically ill patients with acute renal failure.

New Horiz. 1995 Nov;3(4):748-59.

Continuous arteriovenous hemofiltration improvement by adding diffusion and adsorption.

Contrib Nephrol. 1991;93:156-61. doi: 10.1159/000420209.

Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.

Acta Anaesthesiol Scand. 2001 Sep;45(8):929-34. doi: 10.1034/j.1399-6576.2001.450802.x.

Drug removal during continuous hemofiltration or hemodialysis.

Contrib Nephrol. 1991;93:110-6. doi: 10.1159/000420197.

What are the important drug use errors in dialysis patients? Pharmacokinetic and pharmacodynamic principles.

Semin Dial. 2010 Sep-Oct;23(5):466-9. doi: 10.1111/j.1525-139x.2010.00773.x.

The impact of continuous renal replacement therapy on drug therapy.

Clin Pharmacol Ther. 2009 Nov;86(5):562-5. doi: 10.1038/clpt.2009.152. Epub 2009 Sep 2.

[Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Feb;15(2):114-6.

引用本文的文献

Exploring determinants in deciding the optimal antimicrobial dose in patients undergoing CRRT: a mixed-methods study.

Antimicrob Agents Chemother. 2025 Oct;69(10):e0023825. doi: 10.1128/aac.00238-25. Epub 2025 Aug 18.

Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy.

PLoS One. 2024 Dec 19;19(12):e0315643. doi: 10.1371/journal.pone.0315643. eCollection 2024.

Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients.

Pharmaceuticals (Basel). 2024 May 22;17(6):665. doi: 10.3390/ph17060665.

The Clearance of Midazolam and Metabolites during Continuous Renal Replacement Therapy in Critically Ill Patients with COVID-19.

Blood Purif. 2024;53(2):107-113. doi: 10.1159/000534538. Epub 2023 Nov 3.

"CATCH" Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study.

Antibiotics (Basel). 2022 Dec 13;11(12):1811. doi: 10.3390/antibiotics11121811.

Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review.

Antibiotics (Basel). 2022 Dec 7;11(12):1769. doi: 10.3390/antibiotics11121769.

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.

Pharmaceutics. 2022 Apr 11;14(4):842. doi: 10.3390/pharmaceutics14040842.

Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.

Clin Pharmacokinet. 2022 Feb;61(2):189-229. doi: 10.1007/s40262-021-01085-z. Epub 2021 Nov 30.

Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.

J Am Coll Cardiol. 2020 Sep 1;76(9):1084-1101. doi: 10.1016/j.jacc.2020.06.070.

Prevention, Treatment, and Monitoring of Seizures in the Intensive Care Unit.

J Clin Med. 2019 Aug 7;8(8):1177. doi: 10.3390/jcm8081177.

本文引用的文献

Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.

Clin Pharmacokinet. 1993 May;24(5):362-79. doi: 10.2165/00003088-199324050-00002.

Effect of renal failure on drug metabolism by the liver.

Br J Anaesth. 1993 Aug;71(2):282-90. doi: 10.1093/bja/71.2.282.

Drugs and dialysis.

Int J Artif Organs. 1983 May;6(3):139-56.

Extracorporeal therapy in the treatment of intoxication.

Am J Kidney Dis. 1984 Mar;3(5):321-38. doi: 10.1016/s0272-6386(84)80080-3.

Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Clin Pharmacokinet. 1984 Jan-Feb;9(1):42-66. doi: 10.2165/00003088-198409010-00003.

Drug prescribing in renal failure: dosing guidelines for adults.

Am J Kidney Dis. 1983 Nov;3(3):155-93. doi: 10.1016/s0272-6386(83)80060-2.

Optimising of hemodiafiltration with modern membranes?

Contrib Nephrol. 1985;46:43-60. doi: 10.1159/000410766.

Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration.

ASAIO Trans. 1987 Jul-Sep;33(3):300-3.

Solute transport in continuous hemodialysis: a new treatment for acute renal failure.

Kidney Int. 1987 Oct;32(4):562-71. doi: 10.1038/ki.1987.245.

Continuous arteriovenous hemofiltration: an in vitro simulation and mathematical model.

Kidney Int. 1988 Mar;33(3):685-98. doi: 10.1038/ki.1988.54.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验